1-2 of 2
Helmut Dittmann, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dose Escalated Radioimmunotherapy with Yttrium-90-Ibritumomab Tiuxetan as Part of a Reduced Intensity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation in Patients with Advanced Aggressive Non-Hodgkin Lymphoma: An Interim Analysis of a Phase I/II Study

Wolfgang A Bethge, MD, Stephanie von Harsdorf, MD, Martin Bornhauser, MD, Dietrich Beelen, MD, Matthias Stelljes, MD, Rainer Schwerdtfeger, MD, Lutz Uharek, Birgit Federmann, MD, Christoph Faul, MD, Wichard Vogel, MD, Helmut Dittmann, MD, Lothar Kanz, MD, Donald Bunjes, MD
Journal: Blood
Blood (2008) 112 (11): 2995.
https://doi.org/10.1182/blood.V112.11.2995.2995
Published: 2008
Journal Articles

Radioimmunotherapy with Yttrium-90-Ibritumomab Tiuxetan as Part of a Reduced Intensity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation in Patients with Advanced Indolent Non-Hodgkin Lymphoma: Interim Analysis of a Phase II Study.

Wolfgang A Bethge, MD, Thoralf Lange, MD, Stephanie von Harsdorf, MD, Martin Bornhauser, MD, Birgit Federmann, MD, Michael Stadler, MD, Lutz Uharek, Stefan Knop, MD, Gerald Wulf, MD, Helmut Dittmann, MD, Christoph Faul, MD, Wichard Vogel, MD, Lothar Kanz, MD, Donald Bunjes, MD
Journal: Blood
Blood (2008) 112 (11): 1959.
https://doi.org/10.1182/blood.V112.11.1959.1959
Published: 2008